Showing 431-440 of 3356 results for "".
Practical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 2
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-2/32758/Host Neal Bhatia, MD, FAAD, and guests Laura K. Ferris, MD, PhD, FAAD, and Jason E. Hawkes, MD, MS, FAAD, discuss the differences between psoriasis subtypes, the importance of a specialized therapeutic approach targeting the IL-36 pathway for generalized pustular psoriasis, and the role of neutrophiPractical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 6
https://practicaldermatology.com/videos/the-practical-dermatology-roundtable/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-6/32904/In the final installment of a six-part series, host Neal Bhatia, MD, FAAD, and guests Laura K. Ferris, MD, PhD, FAAD, and Jason E. Hawkes, MD, MS, FAAD, recap the recommended protocol for treating generalized psoriasis treatment, starting from the initial diagnosis, as well as the safety of targetedAnnual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/annual-trends-in-medicare-part-d-prescription-claims-for-guselkumab-20182020/28861/Jachin Wu, MD, FAAD, and colleagues talk about Medicare claims for guselkumabSkin Barrier Maintenance in Atopic Dermatitis and Psoriasis
https://practicaldermatology.com/videos/dermatology-dialogues-aryl-hydrocarbon-receptor-agonism/organon-rt-video/70707/In the third installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, describe the importance of skin barrier maintenance in treating inflammatory dermatoses.Managing Patient Expectations with Topical Therapies
https://practicaldermatology.com/videos/dermatology-dialogues-aryl-hydrocarbon-receptor-agonism/managing-patient-expectations-with-topical-therapies/70709/In the fifth installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, talk about the challenges involved with setting treatment goals with inflammatory dermatoses.Mechanism of Action for Aryl Hydrocarbon Receptor Agonists
https://practicaldermatology.com/videos/dermatology-dialogues-aryl-hydrocarbon-receptor-agonism/mechanism-of-action-for-aryl-hydrocarbon-receptor-agonists/70705/In the first installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, discuss the aryl hydrocarbon receptor (AhR) pathway and how AhR agonists work.Tapinarof’s Place in Inflammatory Disease Treatment
https://practicaldermatology.com/videos/dermatology-dialogues-aryl-hydrocarbon-receptor-agonism/tapinarofs-place-in-inflammatory-disease-treatment/70706/In the second installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, explain how tapinarof fits in the armamentarium for treating inflammatory dermatoses.Using Topical Therapies for Pediatric Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology/program-name/70392/In the second installment of this five-part series, Naiem T. Issa, MD, PhD, FAAD, and Maureen N. Offiah, MD, FAAD, explore special considerations when using topical therapies for pediatric patients with atopic dermatitis.How to Treat Seborrheic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology/how-to-treat-seborrheic-dermatitis/70395/In the fifth installment of this five-part series, Naiem T. Issa, MD, PhD, FAAD, and Maureen N. Offiah, MD, FAAD, discuss the complexities involved in treating seborrheic dermatitis.Why Lower-Frequency Dosing Can Be Helpful in Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology/why-lower-frequency-dosing-can-be-helpful-in-atopic-dermatitis/70394/In the fourth installment of this five-part series, Naiem T. Issa, MD, PhD, FAAD, and Maureen N. Offiah, MD, FAAD, describe the importance of a lower-frequency dosing option in treatment for chronic atopic dermatitis.